Interestingly, the HOXA9 locus exhibited heterozygous amplification in more than 50% of patients across the 6 TCGA cancer types, with READ (64.24%) and ESCA (65.21%) showing the highest percentages (Fig. 4C). This evidence concerns the gene HOXA9 and cancer.